Trial
NCT00706615
Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
Ad-sig-hMUC-1/ecdCD40L vaccine
Why stopped
no accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31